When was Mounjaro approved for weight loss in the UK?
Mounjaro was approved for weight loss in the UK on 8 November 2023 by the Medicines and Healthcare products Regulatory Agency (MHRA). In December 2024, NICE recommended its use for weight loss on the NHS in England and Wales for people with a BMI of at least 35 and certain health conditions, with gradual rollout starting in June 2025. Access is currently prioritised for those with the greatest clinical need, and wider availability will expand over time.
- Mounjaro received UK approval for weight loss use on 8 November 2023.
- NICE recommended it for NHS use in England and Wales in December 2024 for people with high BMI and related health conditions.
- NHS rollout began in June 2025, starting with those most in need.
- Wider access will be phased in over several years.
- Eligibility criteria and rollout may differ in Scotland and other parts of the UK.
This text has been fact checked for accuracy by Sorin Romaniuc, Pharmacist at medino.